Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru

BACKGROUND: Nearly half of the world’s population is at risk for dengue, yet no licensed vaccine or anti-viral drug is currently available. Dengue is caused by any of four dengue virus serotypes (DENV-1 through DENV-4), and infection by a DENV serotype is assumed to provide life-long protection agai...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS Negl Trop Dis
Main Authors: Forshey, Brett M., Reiner, Robert C., Olkowski, Sandra, Morrison, Amy C., Espinoza, Angelica, Long, Kanya C., Vilcarromero, Stalin, Casanova, Wilma, Wearing, Helen J., Halsey, Eric S., Kochel, Tadeusz J., Scott, Thomas W., Stoddard, Steven T.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746126/
https://ncbi.nlm.nih.gov/pubmed/26848841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0004398
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados